Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in new...
Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes
About this item
Full title
Author / Creator
Bao, Yu-Qian , Zhou, Jian , Zhou, Mi , Cheng, Yi-Jia , Lu, Wei , Pan, Xiao-Ping , Tang, Jun-Ling , Lu, Hui-Juan and Jia, Wei-Ping
Publisher
Oxford, UK: Blackwell Publishing Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Oxford, UK: Blackwell Publishing Ltd
Subjects
More information
Scope and Contents
Contents
Summary
1. The aim of the present study was to compare the effects of glipizide controlled‐release (CR) tablets monotherapy with that of glipizide CR tablets plus acarbose on glycaemic variability in newly diagnosed Type 2 diabetes (T2DM) patients using a continuous glucose‐monitoring system (CGMS).
2. Forty newly diagnosed T2DM patients whos...
Alternative Titles
Full title
Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_746294799
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_746294799
Other Identifiers
ISSN
0305-1870
E-ISSN
1440-1681
DOI
10.1111/j.1440-1681.2010.05361.x
